The Manitoba government says it has negotiated new lower drug prices with suppliers that will save the government and Manitoba families more than $26 million per year.
At the same time, the province is adding 92 new drugs to its formulary, Health Minister Theresa Oswald said today.
The new drugs include treatments for osteoporosis, HIV (Edurant), multiple sclerosis (Gilenya) and rheumatoid and psoriatic arthritis (Simponi).
"Prescription drugs improve quality of life, help to advance recovery times and save taxpayers money by reducing reliance on more costly forms of medical treatment," said Oswald. "A priority for our government is to secure low prescription drug prices that help Manitobans get the medications they need when they need them."